Compare ALRS & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALRS | SIGA |
|---|---|---|
| Founded | 1879 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 536.4M | 462.6M |
| IPO Year | 2019 | 1997 |
| Metric | ALRS | SIGA |
|---|---|---|
| Price | $23.22 | $6.85 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $25.00 | N/A |
| AVG Volume (30 Days) | 114.4K | ★ 359.7K |
| Earning Date | 01-27-2026 | 11-06-2025 |
| Dividend Yield | 3.59% | ★ 9.01% |
| EPS Growth | ★ 1114.87 | N/A |
| EPS | ★ 1.95 | 1.03 |
| Revenue | ★ $275,452,000.00 | $172,249,641.00 |
| Revenue This Year | $43.58 | N/A |
| Revenue Next Year | $3.26 | $132.36 |
| P/E Ratio | $11.96 | ★ $6.47 |
| Revenue Growth | ★ 67.44 | N/A |
| 52 Week Low | $15.78 | $4.95 |
| 52 Week High | $24.33 | $9.62 |
| Indicator | ALRS | SIGA |
|---|---|---|
| Relative Strength Index (RSI) | 58.54 | 64.55 |
| Support Level | $21.53 | $6.08 |
| Resistance Level | $23.90 | $6.45 |
| Average True Range (ATR) | 0.53 | 0.17 |
| MACD | 0.04 | 0.08 |
| Stochastic Oscillator | 66.03 | 92.50 |
Alerus Financial Corp is a financial holding company registered in the United States. The company operates in four segments: Banking, Retirement & Benefit Services, Wealth Management, and Mortgage. It provides various banking services such as checking, debit cards, savings, current deposits, loans and advances, online banking, mobile banking, private banking, payment solutions, and other business products. Additionally, the company provides mortgage loans, retirement planning solutions, individual retirement accounts, retirement plan advisory services as well as wealth management services, including financial & estate planning, trust, and fiduciary services. The company's revenue mainly consists of interest income, commission, management fees, and other income.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.